Astera Labs, Inc. $ALAB Stock Holdings Boosted by Lido Advisors LLC

Lido Advisors LLC lifted its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 114.8% in the third quarter, according to its most recent filing with the SEC. The firm owned 27,630 shares of the company’s stock after acquiring an additional 14,768 shares during the period. Lido Advisors LLC’s holdings in Astera Labs were worth $9,836,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in ALAB. Keating Financial Advisory Services Inc. acquired a new position in Astera Labs in the second quarter worth about $25,000. Archer Investment Corp bought a new position in Astera Labs during the second quarter worth about $30,000. Transamerica Financial Advisors LLC bought a new position in Astera Labs during the second quarter worth about $35,000. Continuum Advisory LLC bought a new position in Astera Labs during the second quarter worth about $37,000. Finally, GK Wealth Management LLC acquired a new stake in Astera Labs during the third quarter valued at approximately $29,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Astera Labs

Here are a few of the latest headlines about ALAB:

• Positive Sentiment: Northland raised its FY2026 EPS estimate to $2.99 from $2.75 and its Q4 2026 estimate to $1.25 from $1.09, while maintaining an Outperform rating and $315 price target. Analyst estimate details
• Neutral Sentiment: A short-interest entry claims a large increase but reports total short interest of zero shares, making the data contradictory and unhelpful as a clear trading signal.
• Negative Sentiment: ETFs were net sellers of $80.2 million of ALAB in the Nov. 6 session, indicating notable fund outflows that may add selling pressure. ETF selling report

Insider Activity at Astera Labs

In other news, CEO Jitendra Mohan sold 90,630 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. The trade was a 6.68% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the transaction, the general counsel directly owned 96,542 shares in the company, valued at $32,872,551. The trade was a 6.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 408,558 shares of company stock valued at $126,050,884. Insiders own 10.40% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Barclays upped their price objective on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research note on Monday, July 20th. Wall Street Zen upgraded Astera Labs from a “hold” rating to a “buy” rating in a research report on Saturday, November 7th. Weiss Ratings downgraded Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research report on Friday, October 23rd. Jefferies Financial Group boosted their price target on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Finally, TD Cowen lowered their price target on Astera Labs from $300.00 to $225.00 and set a “hold” rating on the stock in a research report on Wednesday, November 4th. Thirteen investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $320.85.

Astera Labs Stock Up 6.8%

Shares of Astera Labs stock opened at $230.91 on Thursday. The stock has a market capitalization of $40.36 billion, a P/E ratio of 92.00 and a beta of 3.85. The company has a 50-day simple moving average of $296.41 and a 200 day simple moving average of $256.51. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.13. The firm had revenue of $584.90 million during the quarter, compared to the consensus estimate of $550.78 million. Astera Labs had a net margin of 29.64% and a return on equity of 25.35%. The firm’s quarterly revenue was up 153.6% on a year-over-year basis. During the same period last year, the firm posted $0.49 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 2.99 earnings per share for the current year.

About Astera Labs

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.